IP Library Granted Patent US 8,748,405
Granted Patent B2
US 8,748,405 · App. 13/229,146 · Granted Jun 10, 2014

Methods and compositions for the treatment of cancer or other diseases

Inventors: Hua Yu (Glendora, CA); Marcin Kortylewski (Monrovia, CA); Richard Jove (Glendora, CA); Piotr Marek Swiderski (San Dimas, CA); John J. Rossi (Alta Loma, CA)
Assignee: City of Hope
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,748,405
App. No.
13/229,146
Granted
Jun 10, 2014
Kind
B2
Abstract

The present invention relates to methods and compositions for the treatment of diseases, including cancer, infectious diseases and autoimmune diseases. The present invention also relates to methods and compositions for improving immune function. More particularly, the present invention relates to multifunctional molecules that are capable of being delivered to cells of interest for the treatment of diseases and for the improvement in immune function.

Claims (3)

1. A chimeric molecule comprising a human STAT3 sense strand and a human CpG(D19)-STAT3 antisense strand, wherein the human STAT3 sense strand comprises an oligonucleotide having nucleotides set forth in SEQ ID NO:4, wherein the human CpG(D19)-STAT3 antisense strand comprises (a) a first oligonucleotide having the nucleotides set forth in SEQ ID NO:16, (b) a C3 carbon chain or propanediol linker and (c) a second oligonucleotide having the nucleotides set forth in SEQ ID NO:5 that is the antisense strand, and wherein the sense strand and the antisense strand anneal to form a double stranded siRNA.

2. A method of treating a disease which comprises administering a therapeutically effective amount of the molecule of claim 1 to an individual in need thereof, wherein the disease is one that can be treated by regulating the Stat3 pathway or genes under control of Stat3.

3. The method of claim 2 , wherein the disease is selected from the group consisting of cancer, an infectious disease and an autoimmune disease.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2018
From: YU, HUA; KORTYLEWSKI, MARTIN; JOVE, RICHARD; SWIDERSKI, PIOTR MAREK; ROSSI, JOHN J
To: CITY OF HOPE
Reel/Frame 047552/0151 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2011
From: YU, HUA; KORTYLEWSKI, MARCIN; JOVE, RICHARD; SWIDERSKI, PIOTR MAREK; ROSSI, JOHN J.
To: CITY OF HOPE
Reel/Frame 027275/0351 →
Continuity (6)
Continuation In Part 12879199 · Sep 10, 2010
Continuation In Part 11966423 · Dec 28, 2007
Provisional Application 61466086 · Mar 22, 2011
Provisional Application 61241764 · Sep 11, 2009
Provisional Application 60897495 · Jan 26, 2007
Related Publication 20120065125A1 · Mar 15, 2012